NSETrading Window24 Jun 2026 · 24 Jun 2026, 11:36 am

Trading Window

Bal Pharma Limited · BALPHARMA

✦ AI SummaryResults

Bal Pharma Limited has informed the Exchange regarding the closure of the trading window for dealing with the company's securities due to the declaration of unaudited financial results for the quarter ended 30/06/2026.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact8/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

BALPHARMA_24062026113551_Closure_of_Trading_Window.pdf

pdf

Download →

View document text

Corporate Office BAL PHARMA LIMITED © © +i9n1f8o0@ b4a1l3p7 ha95r0m0a .com © Sth Floor, Lakshmi Narayan Complex, 10/1, Palace Road, Bangalore - 560 052, India. 24.06.2026 The Manager-Listing National Stock Exchange of India Ltd Mumbai. BSE Limited Mumbai. Dear Sir, Sub : Closure of Trading Window. Pursuant to the Code of conduct of the Company and as per the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform the exchange that the trading window for dealing with the securities of the Company on the designated persons and their immediate relatives will be closed from 1°! July 2026 and up to 48 hours of the declaration of the unaudited financial results of the Company for the quarter ended 30/06/2026. The date of the Board meeting for declaration of the unaudited financial results will be intimated to the exchange in due course. Please take this intimation on record. Thanking You. For Bal Pharma Limited Authorized Signatory. Registered Office : Plot No. 21 & 22, Bommasandra Industrial Area, Bengaluru - 560 099, Karnataka, INDIA. Ph: +91 80 41570811/813. CIN # L8S5NOKAI987PLCO08368 :